Tech

October 12, 2012

NASA signs agreement to develop nasal spray for motion sickness

NASA’s Johnson Space Center in Houston and Epiomed Therapeutics Inc. of Irvine, Calif., have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness.

Under the Space Act Agreement, Epiomed will formulate the drug, called intranasal scopolamine, or INSCOP. Astronauts often experience motion sickness in space. As a result, NASA has conducted extensive research into the causes and treatments for the condition. Scopolamine is effective and can be administered as a tablet or injected. With

precise dosage, the NASA spray formulation has been shown to work faster and more reliably than the oral form.

“NASA and Epiomed will work closely together on further development of INSCOP to optimize therapeutic efficiency for both acute and chronic treatment of motion sickness which can be used by NASA, the Department of Defense and world travelers on land, in the air and on the seas,” said Lakshmi Putcha, developer of the innovative treatment strategy at Johnson.

A gel formulation of INSCOP was developed and tested under a Space Act Agreement between Johnson and the Naval Aerospace Medical Research Laboratory in Pensacola, Fla. Results from that trial were published in the journal Aviation, Space and Environmental Medicine in April 2010 that suggest INSCOP is a fast-acting and reliable way to prevent and treat motion sickness.

The U.S. Navy is working on an agreement with Epiomed to test the nasal spray. NASA and Epiomed will collaborate on clinical trials related to the Federal Drug Administration requirements. NASA is transferring sponsorship of future clinical trials and FDA approvals to Epiomed, which will supply the product for use by NASA and others.

 




All of this week's top headlines to your email every Friday.


 
 

 
darpa-notice

DARPA Tactical Technology Office invites innovative risk-takers to attend 2014 Office-Wide Proposers Day

DARPAs Tactical Technology Office invests in innovative platforms, weapons, integrated systems and critical systems components that often incorporate emerging advanced technologies, all designed to preserve and extend decisive ...
 
 

AFRL provides environmentally-preferred alternatives for removing radome coatings

Radomes, tail cones, and other fiberglass or composite components on E-3, KC-135, and B-52 aircraft are coated with polyurethane rain erosion resistant coatings to protect them from the effects of rain erosion in flight. Oklahoma City Air Logistics Complex (OC-ALC) production workers must remove the coatings during depot overhaul to allow for inspection and repair....
 
 
darpa-uav-network

Remote troops closer to having high-speed wireless networks mounted on UAVs

Missions in remote, forward operating locations often suffer from a lack of connectivity to tactical operation centers and access to valuable intelligence, surveillance, and reconnaissance data. The assets needed for long-range...
 

 
Photograph courtesy of Research Center for Marine Geosciences/DLR

NASA signs agreement with German, Canadian partners to test alternative fuels

NASA photograph A heavily instrumented NASA HU-25 Falcon measures chemical components from the larger DC-8′s exhaust generated by a 50/50 mix of conventional jet fuel and a plant-derived biofuel, demonstrating the type of...
 
 
darpa-phoenix2

Phoenix makes strides in orbital robotics, satellite architecture research

The process of designing, developing, building and deploying satellites is long and expensive. Satellites today cannot follow the terrestrial paradigm of “assemble, repair, upgrade, reuse,” and must be designed to operate w...
 
 

AFRL researchers uncover structural, function relationships in bioinspired nanomaterials

In his 1954 work, The Nature of Science, Edwin Powell Hubble said, “Equipped with his five senses, man explores the universe around him and calls the adventure Science.” During his tenure with the Air Force Research Laboratory, National Research Council associate Dr. Nick Bedford, embarked on such an adventure that applied both biological and physical...
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>